Literature DB >> 33574277

Mapping of susceptible variants for cold medicine-related Stevens-Johnson syndrome by whole-genome resequencing.

Yosuke Kawai1,2, Yuki Hitomi1,3, Mayumi Ueta4, Seik-Soon Khor1,2, Ken Nakatani1, Chie Sotozono5, Shigeru Kinoshita6, Masao Nagasaki7,8,9, Katsushi Tokunaga10,11.   

Abstract

Stevens-Johnson syndrome (SJS) and its severe condition with extensive skin detachment and a poor prognosis, toxic epidermal necrolysis (TEN), are immunologically mediated severe cutaneous reactions of the skin and mucous membranes such as the ocular surface. Genetic variations on the HLA-A and other autosomal genes have been identified as risk factors for cold medicine-related SJS/TEN with severe ocular complications (CM-SJS/TEN with SOC). Using a whole-genome sequencing (WGS) approach, we explored other susceptible variants of CM-SJS/TEN with SOC, especially among rare variants and structural variants (SVs). WGS was performed on samples from 133 patients with CM-SJS/TEN with SOC and 418 healthy controls to obtain single nucleotide polymorphisms (SNPs) and SVs. Genome-wide association tests were performed with these variants. Our genome-wide association test reproduced the associations of the common variants of HLA-A and loci on chromosome 16q12.1. We also identified novel associations of SVs on these loci and an aggregation of rare coding variants on the TPRM8 gene. In silico gene expression analysis on the HLA-A locus revealed that the SNP (rs12202296), which was significantly associated with susceptibility to CM-SJS/TEN with SOC, was correlated to an increase in HLA-A expression levels in the whole blood (P = 2.9 × 10-17), from the GTEx database. The majority of variants that were significantly associated with CM-SJS/TEN with SOC were found in non-coding regions, indicating the regulatory role of genetic variations in the pathogenesis of CM-SJS/TEN with SOC.

Entities:  

Year:  2021        PMID: 33574277     DOI: 10.1038/s41525-021-00171-2

Source DB:  PubMed          Journal:  NPJ Genom Med        ISSN: 2056-7944            Impact factor:   8.617


  47 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

Authors:  Mark McCormack; Ana Alfirevic; Stephane Bourgeois; John J Farrell; Dalia Kasperavičiūtė; Mary Carrington; Graeme J Sills; Tony Marson; Xiaoming Jia; Paul I W de Bakker; Krishna Chinthapalli; Mariam Molokhia; Michael R Johnson; Gerard D O'Connor; Elijah Chaila; Saud Alhusaini; Kevin V Shianna; Rodney A Radtke; Erin L Heinzen; Nicole Walley; Massimo Pandolfo; Werner Pichler; B Kevin Park; Chantal Depondt; Sanjay M Sisodiya; David B Goldstein; Panos Deloukas; Norman Delanty; Gianpiero L Cavalleri; Munir Pirmohamed
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

3.  A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.

Authors:  Christine Lonjou; Nicolas Borot; Peggy Sekula; Neil Ledger; Laure Thomas; Sima Halevy; Luigi Naldi; Jan-Nico Bouwes-Bavinck; Alexis Sidoroff; Claudia de Toma; Martin Schumacher; Jean-Claude Roujeau; Alain Hovnanian; Maja Mockenhaupt
Journal:  Pharmacogenet Genomics       Date:  2008-02       Impact factor: 2.089

4.  Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.

Authors:  Yumiko Yamane; Michiko Aihara; Zenro Ikezawa
Journal:  Allergol Int       Date:  2007-09-01       Impact factor: 5.836

5.  Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Chie Sotozono; Mayumi Ueta; Eiji Nakatani; Amane Kitami; Hideaki Watanabe; Hirohiko Sueki; Masafumi Iijima; Michiko Aihara; Zenro Ikezawa; Yukoh Aihara; Yoko Kano; Tetsuo Shiohara; Mikiko Tohyama; Yuji Shirakata; Hideaki Kaneda; Masanori Fukushima; Shigeru Kinoshita; Koji Hashimoto
Journal:  Am J Ophthalmol       Date:  2015-05-13       Impact factor: 5.258

6.  The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.

Authors:  H L Chan; R S Stern; K A Arndt; J Langlois; S S Jick; H Jick; A M Walker
Journal:  Arch Dermatol       Date:  1990-01

7.  Etiologic factors of the Stevens-Johnson syndrome.

Authors:  J Z Yetiv; J R Bianchine; J A Owen
Journal:  South Med J       Date:  1980-05       Impact factor: 0.954

8.  Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.

Authors:  Takeshi Ozeki; Taisei Mushiroda; Amara Yowang; Atsushi Takahashi; Michiaki Kubo; Yuji Shirakata; Zenro Ikezawa; Masafumi Iijima; Tetsuo Shiohara; Koji Hashimoto; Naoyuki Kamatani; Yusuke Nakamura
Journal:  Hum Mol Genet       Date:  2010-12-10       Impact factor: 6.150

9.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 10.  SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

Authors:  Katie D White; Riichiro Abe; Michael Ardern-Jones; Thomas Beachkofsky; Charles Bouchard; Bruce Carleton; James Chodosh; Ricardo Cibotti; Robert Davis; Joshua C Denny; Roni P Dodiuk-Gad; Elizabeth N Ergen; Jennifer L Goldman; James H Holmes; Shuen-Iu Hung; Mario E Lacouture; Rannakoe J Lehloenya; Simon Mallal; Teri A Manolio; Robert G Micheletti; Caroline M Mitchell; Maja Mockenhaupt; David A Ostrov; Rebecca Pavlos; Munir Pirmohamed; Elena Pope; Alec Redwood; Misha Rosenbach; Michael D Rosenblum; Jean-Claude Roujeau; Arturo P Saavedra; Hajirah N Saeed; Jeffery P Struewing; Hirohiko Sueki; Chonlaphat Sukasem; Cynthia Sung; Jason A Trubiano; Jessica Weintraub; Lisa M Wheatley; Kristina B Williams; Brandon Worley; Wen-Hung Chung; Neil H Shear; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.